跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
Analýza sublingvální mikrovaskulární glykokalyx u pacientů v intenzivní péči – prospektivní observační studie
D. Astapenko, P. Dostál, R. Černá Pařízková, R. Škulec,
Vladimír Černý
科研成果
:
期刊稿件
›
文章
›
同行评审
1
引用 (Scopus)
综述
指纹
指纹
探究 'Analýza sublingvální mikrovaskulární glykokalyx u pacientů v intenzivní péči – prospektivní observační studie' 的科研主题。它们共同构成独一无二的指纹。
分类
加权
按字母排序
Keyphrases
Prospective Observational Study
100%
Critically Ill Patients
100%
Perfused Boundary Region
100%
Glycocalyx
100%
Sublingual
100%
Endothelial Glycocalyx
33%
Intensive Care Unit
22%
Critical Illness
22%
Septic Shock
22%
Positive Fluid Balance
22%
Non-invasive Method
11%
Length of Stay
11%
Adult Patients
11%
Illness
11%
No Significant Difference
11%
Demographic Data
11%
Sepsis
11%
Clinical Data
11%
Clinical Conditions
11%
Sublingual Microcirculation
11%
Assessment Method
11%
Weak Predictors
11%
Method Assessment
11%
University Hospital
11%
Suitable Method
11%
Endothelial Glycocalyx Damage
11%
Renal Replacement Therapy
11%
Monocentric
11%
SOFA Score
11%
Coupling Functions
11%
Region-based Analysis
11%
Sudden Onset
11%
APACHE II Score
11%
Inter-individual Variability
11%
Organ Support
11%
Tissue Metabolism
11%
Nursing and Health Professions
Intensive Care Unit
100%
Critical Illness
100%
Septic Shock
100%
Continuous Renal Replacement Therapy
100%
Length of Stay
50%
Disease
50%
Sepsis
50%
APACHE
50%
Renal Replacement Therapy
50%
University Hospital
50%
Sequential Organ Failure Assessment Score
50%
Non Invasive Procedure
50%
Medicine and Dentistry
Observational Study
100%
Glycocalyx
100%
Intensive Care Unit
40%
Microcirculation
40%
Critical Illness
40%
Septic Shock
40%
Continuous Renal Replacement Therapy
40%
Fluid Balance
40%
Disease
20%
Non Invasive Procedure
20%
Sepsis
20%
Renal Replacement Therapy
20%
APACHE II
20%
SOFA Score
20%
Tissue Metabolism
20%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Septic Shock
100%
Critical Illness
100%
Disease
50%
Sepsis
50%
Replacement Therapy
50%